Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
23.46
+0.75 (3.30%)
At close: Nov 4, 2024, 4:00 PM
22.70
-0.76 (-3.24%)
Pre-market: Nov 5, 2024, 6:00 AM EST
Bicycle Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 1,619 | 767 | 879 | 1,790 | 382 | 169 | |
Market Cap Growth | 87.63% | -12.72% | -50.89% | 367.96% | 126.52% | - | |
Enterprise Value | 700 | 241 | 561 | 1,563 | 248 | 75 | |
Last Close Price | 23.46 | 18.08 | 29.60 | 60.87 | 17.95 | 9.43 | |
PE Ratio | - | -3.56 | -7.79 | -22.80 | -6.74 | -3.40 | |
PS Ratio | 32.77 | 28.43 | 60.76 | 152.99 | 36.81 | 12.23 | |
PB Ratio | 1.85 | 2.07 | 3.25 | 5.17 | 4.01 | 1.81 | |
P/FCF Ratio | - | -12.07 | -8.36 | -106.37 | -20.14 | -5.60 | |
P/OCF Ratio | - | -12.65 | -10.21 | -120.97 | -21.50 | -5.90 | |
EV/Sales Ratio | 18.97 | 8.92 | 38.81 | 133.63 | 23.90 | 5.43 | |
EV/EBITDA Ratio | -3.38 | -1.31 | -4.97 | -24.34 | -4.90 | -2.96 | |
EV/EBIT Ratio | -3.27 | -1.27 | -4.81 | -23.82 | -4.78 | -2.85 | |
EV/FCF Ratio | - | -3.79 | -5.34 | -92.91 | -13.08 | -2.48 | |
Debt / Equity Ratio | 0.05 | 0.12 | 0.16 | 0.13 | 0.17 | 0.02 | |
Debt / FCF Ratio | - | -0.71 | -0.42 | -2.64 | -0.83 | -0.06 | |
Asset Turnover | - | 0.05 | 0.03 | 0.04 | 0.08 | 0.14 | |
Quick Ratio | - | 7.92 | 6.76 | 12.43 | 6.51 | 11.25 | |
Current Ratio | - | 8.08 | 6.92 | 12.65 | 6.73 | 11.81 | |
Return on Equity (ROE) | - | -56.31% | -36.53% | -30.25% | -54.08% | -42.05% | |
Return on Assets (ROA) | - | -23.60% | -16.38% | -12.80% | -23.94% | -17.14% | |
Return on Capital (ROIC) | -17.82% | -32.48% | -20.66% | -16.34% | -31.48% | -22.29% | |
Earnings Yield | -10.27% | -23.56% | -12.83% | -3.73% | -13.34% | -18.13% | |
FCF Yield | -8.29% | -11.96% | -0.94% | -4.97% | -17.87% | |
Buyback Yield / Dilution | -59.12% | -20.00% | -18.35% | -30.90% | -73.34% | -2416.82% | |
Total Shareholder Return | -59.12% | -20.00% | -18.35% | -30.90% | -73.34% | -2416.82% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.